Download PDF
Int J Angiol 2023; 32(04): 233-237
DOI: 10.1055/s-0043-1768981
Original Article

Impact of Ablation during Index Hospitalization on All-Cause Mortality in Patients with Typical Atrial Flutter: Insights from National Multicenter Database

Muhammad Amer
1   CAMC Vascular Center of Excellence, Charleston Area Medical Center, Charleston, West Virginia
,
Frank H. Annie 
2   CAMC Health Education and Research Institute, Charleston, West Virginia
,
Shubash Adhikari
1   CAMC Vascular Center of Excellence, Charleston Area Medical Center, Charleston, West Virginia
,
Debabrata Mukherjee 
3   Texas Tech University Health Sciences Center at El Paso, El Paso, Texas
› Author Affiliations Funding The article was funded by National Institute of General Medical Sciences (grant Number: 5U54GM104942-04).
› Further Information
    Permissions and Reprints

Abstract

Background We sought to assess the impact of ablation during index hospitalization (IH) on all-cause mortality (ACM) in patients presenting with newly diagnosed typical atrial flutter (tAFL) as compared with patients without ablation, irrespective of optimal rate or rhythm control medications.

Methods We identified patients with newly diagnosed tAFL in the TriNetX Research Network between January 20, 2010, and January 20, 2021. Using International Classification of Diseases, 10th revision (ICD-10) codes, patients were stratified into those who had undergone ablation during IH and those who did not undergo the procedure. Results were assessed using propensity score matching (PSM) analysis as well as Kaplan–Meier curves.

Results A total of 12,986 (N) patients (aged 35–85 years) met our inclusion criteria. Of those, 3,665 had undergone ablation during IH compared with 9,321 patients who did not. Patients in the ablation group (mean age 64.3 ± 10.1 years) had a higher prevalence of hypertension (80 vs. 78.3%, p = 0.02), respectively. PSM created two well-matched groups of 3,652/3,652 patients each with an ACM of ablation of 4.5 versus 7.8% (p = 0.01) at 6 months, 6.6 versus 11.4% (p = 0.01) at 12 months, and 14.5 versus 20.9% (p < 0.001) at 36 months of follow-up. Survival data were confirmed through Kaplan–Meier analysis using a log-rank test.

Conclusion From a large, federated, multicenter population database, we report significant survival benefit of ablation during IH in patients presenting with new tAFL diagnosis. Kaplan–Meier mortality curves confirmed survival advantage with ablation at 6, 12, and 36 months of follow-up in this cohort.

Keywords

ablation - all-cause mortality - typical atrial flutter - cardiovascular mortality


Publication History

Article published online:
14 May 2023

© 2023. International College of Angiology. This article is published by Thieme.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Granada J, Uribe W, Chyou PH. et al. Incidence and predictors of atrial flutter in the general population. J Am Coll Cardiol 2000; 36 (07) 2242-2246
    CrossrefPubMedGoogle Scholar
  • 2 Page RL, Joglar JA, Caldwell MA. et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm 2016; 13 (04) e136-e221
    CrossrefPubMedGoogle Scholar
  • 3 Calkins H, Canby R, Weiss R. et al; 100W Atakr II Investigator Group. Results of catheter ablation of typical atrial flutter. Am J Cardiol 2004; 94 (04) 437-442
    CrossrefPubMedGoogle Scholar
  • 4 Spector P, Reynolds MR, Calkins H. et al. Meta-analysis of ablation of atrial flutter and supraventricular tachycardia. Am J Cardiol 2009; 104 (05) 671-677
    CrossrefPubMedGoogle Scholar
  • 5 Anselme F, Saoudi N, Poty H, Douillet R, Cribier A. Radiofrequency catheter ablation of common atrial flutter: significance of palpitations and quality-of-life evaluation in patients with proven isthmus block. Circulation 1999; 99 (04) 534-540
    CrossrefPubMedGoogle Scholar
  • 6 Dewland TA, Glidden DV, Marcus GM. Healthcare utilization and clinical outcomes after catheter ablation of atrial flutter. PLoS One 2014; 9 (07) e100509 DOI: 10.1371/journal.pone.0100509.
    CrossrefPubMedGoogle Scholar
  • 7 Clementy N, Desprets L, Pierre B. et al. Outcomes after ablation for typical atrial flutter (from the Loire Valley Atrial Fibrillation Project). Am J Cardiol 2014; 114 (09) 1361-1367
    CrossrefPubMedGoogle Scholar
  • 8 Yugo D, Chen YY, Lin YJ. et al. Long-term mortality and cardiovascular outcomes in patients with atrial flutter after catheter ablation. Europace. Published online December 23, 2021:euab308. Doi:10.1093/europace/euab308
    PubMedGoogle Scholar
  • 9 Olsson KM, Nickel NP, Tongers J, Hoeper MM. Atrial flutter and fibrillation in patients with pulmonary hypertension. Int J Cardiol 2013; 167 (05) 2300-2305
    CrossrefPubMedGoogle Scholar
  • 10 Jani C, Arora S, Zuzek Z. et al. Impact of catheter ablation in patients with atrial flutter and concurrent heart failure. Heart Rhythm O2 2020; 2 (01) 53-63
    CrossrefPubMedGoogle Scholar